Clinical Trial Drug Supply Predictions Making Them Realistic and Near Real-Time

Course Overview

Clinical trial drug supply requirements depend on when Patient Visits occur, and CMOs and CDMOs are criticized for not providing the drug supplies on time and budget. However, they struggle to improve their performance because those who plan and oversee the clinical trials don’t have a satisfactory way to indicate when Patient Visits will occur.

As a result, the CMOs and CDMOs cannot efficiently sequence their manufacturing campaigns and follow-on steps, resulting in waste levels that can reach 80%.

In this webinar, Steve Glan will show you that more accurate clinical trial drug supply predictions are possible, even when things go wrong during trial execution.

Steve has spent the last decade making clinical trial design and execution predictable, efficient, and transparent by applying his knowledge of engineering, manufacturing, clinical operations, math, and software development to large sets of clinical trial data.

By the end of the webinar, you will see the explicit connection between Patient Visits and clinical trial drug supply, improving planning between CROs/Pharma ClinOps and CMOs/CDMOas.